News | September 11, 2014

Poor Health Literacy Poses Risks for Pacemaker and Defibrillator Patients


September 11, 2014 — Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they don’t fully understand how the devices work and what to do when they experience an irregular heartbeat. But a study from Columbia University School of Nursing, published in the Journal of Cardiovascular Nursing, found that 40 percent of patients with these devices had little to no ability to understand information about their cardiac health.

“As a nurse practitioner, I use every patient encounter as an opportunity for education,” said lead author Kathleen Hickey, EdD, ANP-BC, FNP-BC, assistant professor at Columbia Nursing. “Health literacy is a particular concern for patients with pacemakers and defibrillators because these patients need to know how to respond if they get a shock from their device. Even when the device is quiet they often need to know how to manage co-existing health conditions like diabetes, heart failure and high blood pressure.”

Risks can stem from some common misunderstandings between patients and clinicians, Hickey said. A patient might ignore advice to avoid rigorous exercise and then be surprised when experiencing an irregular heartbeat, for example. Or, patients instructed to check their pulse regularly and report any abnormal activity might not understand how to do this or what heart rate is cause for alarm. “It’s not enough just to explain the same thing again in the same way,” she said. “You have to stop to ask more specific questions like what activities they do in a typical day and offer simple instructions so they understand, for example, the appropriate heart rate zone for exercise."

To understand the scope of potential communication problems, Hickey and a team of researchers evaluated the health literacy of 116 patients using a standard measure of reading and math comprehension, the Test of Functional Health Literacy in Adults. The study population was ethnically diverse: 37.1 percent white, 39.7 percent Hispanic and 22.4 percent African-American; 77.4 percent of the population reported finishing high school. The average age of the study population was 68. Evaluations were done in English or Spanish. Almost 30 percent of participants had inadequate health literacy, and an additional 10 percent were marginal.

The study also examined literacy among patients with medical conditions that are common among patients with pacemakers and defibrillators. Individuals with hypertension or high cholesterol were more than twice as likely to have limited health literacy as individuals without those conditions. Diabetics were almost twice as likely to have low health literacy.

“The good news here is that people are living longer with these devices,” Hickey said. “The problem is that co-morbidities like diabetes and hypertension can worsen with age, at the same time that cognitive function declines. This makes it more urgent, and more difficult, to improve health literacy.”

The Centers for Disease Control and Prevention define health literacy as the degree to which an individual has the ability to obtain, communicate and comprehend basic health information and treatments to make appropriate decisions about care. Limited health literacy is associated with poorer health outcomes, higher rates of hospitalizations, increased use of the emergency department, improper use of medications and higher healthcare costs.

The study is titled “Assessing Health Literacy in Urban Patients with Implantable Cardioverter Defibrillators (ICDs) and Pacemakers.” The authors declared no financial or other conflicts of interest.

For more information: www.nursing.columbia.edu


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now